Twist Bioscience Stock Soars 7.16%, Hits Intraday High of $34.18

Twist Bioscience Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a significant uptick in its stock performance, gaining 7.16% on October 24, 2025. The stock reached an intraday high of USD 34.18, reflecting a strong day of trading activity. Over the past week, Twist Bioscience has shown impressive growth, with a 21.13% increase, significantly outpacing the S&P 500's 1.92% rise. The company's one-month performance stands at 26.24%, again surpassing the S&P 500's 2.32%. However, it is noteworthy that the stock has faced challenges over the longer term, with a one-year decline of 15.23% and a year-to-date drop of 26.6%. Financial metrics indicate a robust growth in net sales, reported at 17.91%, and a high inventory turnover ratio of 6.76 times. The company also boasts high institutional holdings at 100%, suggesting strong backing from investors with substantial analytical resources. Despite its current challenges, Twist Bioscience continues to demonstrate notable activity in the market.